Addison Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $107K | Sell |
1,533
-242
| -14% | -$16.9K | 0.03% | 301 |
|
|
2025
Q1 | $130K | Buy |
1,775
+42
| +2% | +$3.09K | 0.04% | 262 |
|
|
2024
Q4 | $114K | Sell |
1,733
-10
| -0.6% | -$655 | 0.03% | 283 |
|
|
2024
Q3 | $136K | Buy |
1,743
+186
| +12% | +$14.5K | 0.04% | 266 |
|
|
2024
Q2 | $121K | Buy |
1,557
+495
| +47% | +$38.6K | 0.04% | 265 |
|
|
2024
Q1 | $72K | Buy |
1,062
+66
| +7% | +$4.47K | 0.02% | 319 |
|
|
2023
Q4 | $67.1K | Buy |
996
+266
| +36% | +$17.9K | 0.03% | 317 |
|
|
2023
Q3 | $49.4K | Buy |
730
+232
| +47% | +$15.7K | 0.02% | 322 |
|
|
2023
Q2 | $35.6K | Buy |
498
+35
| +8% | +$2.51K | 0.02% | 358 |
|
|
2023
Q1 | $32.1K | Sell |
463
-38
| -8% | -$2.64K | 0.02% | 348 |
|
|
2022
Q4 | $34K | Sell |
501
-404
| -45% | -$27.4K | 0.02% | 321 |
|
|
2022
Q3 | $50K | Buy |
905
+32
| +4% | +$1.77K | 0.03% | 262 |
|
|
2022
Q2 | $58K | Sell |
873
-214
| -20% | -$14.2K | 0.04% | 242 |
|
|
2022
Q1 | $72K | Buy |
1,087
+533
| +96% | +$35.3K | 0.04% | 238 |
|
|
2021
Q4 | $32K | Buy |
554
+521
| +1,579% | +$30.1K | 0.02% | 283 |
|
|
2021
Q3 | $2K | Buy |
33
+16
| +94% | +$970 | ﹤0.01% | 371 |
|
|
2021
Q2 | $1K | Buy |
+17
| New | +$1K | ﹤0.01% | 376 |
|
|
2020
Q4 | $1K | Buy |
+17
| New | +$1K | ﹤0.01% | 361 |
|